EQT Fund Management S.a r.l.

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 13, 2026), EQT Fund Management S.a r.l. reported 5 stock positions worth $862.6 million. Its top holding was Waystar (WAY) at 59.2% of the portfolio, followed by Pharvaris (PHVS, 13.7%) and Oculis (OCS, 11.2%). Compared with Q1 2026, it added to 2. The biggest buy was Evommune (EVMN, shares +7%).

Most Recent 13F
Q2 2026
Location
LUXEMBOURG, N4
CIK
0001834239
Portfolio Value
$862.6M (Q2 2026)
SEC Filing
0001193125-26-349398 ↗ filed Aug 13, 2026

Holdings Value

0$500.0M$1.0B$1.5B$2.0B Q3 2025: $1.9B Q3 2025 Q4 2025: $1.1B Q4 2025 Q1 2026: $1.0B Q1 2026 Q2 2026: $862.6M $862.6M Q2 2026

Holdings 5 stocks · $862.6M
WAY Waystar Holding Corp. 59.21% 24,879,437 $510.8M No change
PHVS Pharvaris NV 13.73% 3,424,609 $118.4M No change
OCS Oculis Holding AG 11.18% 6,950,294 $96.4M Add +17.8%
EVMN Evommune Inc. 8.15% 5,288,313 $70.3M Add +7.3%
AGMB Agomab Therapeutics NV 7.74% 5,141,992 $66.7M No change

Portfolio Sells Q1 2026 → Q2 2026
None this quarter.

Portfolio Buys Q1 2026 → Q2 2026
EVMN Evommune Inc. Add +7.3% 8.15% −2.96
OCS Oculis Holding AG Add +17.8% 11.18% −4.19

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 5$862.6MWAY, PHVS, OCS, EVMN, AGMB
Q1 2026 5$1.0BWAY, OCS, EVMN, PHVS, AGMB
Q4 2025 4$1.1BWAY, OCS, PHVS, EVMN
Q3 2025 4$1.9BWAY, KGS, OCS, PHVS